ArticleSchizophrenia (Heidelberg, Germany)2026
A new mechanism underlying mitochondrial dysfunction in schizophrenia - attenuated mRNA transport of the complex I subunit NDUFV2 by its pseudogene NDUFV2P1.
Article in Schizophrenia (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
While schizophrenia (SZ) etiology remains unclear, accumulating evidence implicates mitochondrial dysfunction, particularly complex-I of the respiratory chain and its essential free-electron scavenger subunit, NDUFV2, as a contributor to neuronal and behavioral impairments observed in SZ. Our recent studies suggest a potential role for the NDUFV2 pseudogene (NDUFV2P1) in NDUFV2 deficits. Here, we describe a mechanism by which NDUFV2P1 negatively controls NDUFV2 mRNA transport and its protein levels in SZ-derived lymphocyte cell lines (SZ-LCLs). We found increased NDUFV2P1 transcript levels in SZ frontal cortex postmortem specimens (SZ-FCX) and across all studied SZ-LCLs subcellular fractions. However, NDUFV2 levels were reduced in SZ-FCX and in all cell compartments, except for the nucleus, as compared to healthy subjects-derived LCLs (CTL-LCLs), suggesting its impaired nuclear export. Concomitantly, we observed increased NDUFV2P1, yet decreased NDUFV2 mRNA binding to NXF1, a key player in nuclear mRNA export. Overexpression of NDUFV2P1 in CTL-LCLs mimicked the SZ-state, reducing NDUFV2 levels and its binding to NXF1. The interactome of both mRNAs revealed an opposite binding profile for most RNA-binding proteins (RBPs) in SZ-LCLs compared to CTL-LCLs. Pathway enrichment analysis of the differentially bound RBPs to both transcripts revealed additional potential interference sites for NDUFV2 and NDUFV2P1, including ribosomal-, spliceosome-, and RNA transport-related RBPs. This study uncovers a new mechanism in which NDUFV2P1 interferes with RBPs involved in regulating NDUFV2 transport from the nucleus to mitochondrial-bound ribosomes. While further validation is necessary to substantiate this mechanism, the findings highlight NDUFV2P1 potential as a means for regulating mitochondrial function and consequently energy metabolism in SZ.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.